Purchase Order 75N91021P00781
Award Date 8/24/21
Potential Completion Date 12/31/21
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute issued a purchase order to Qiagen, LLC on December 18, 2020, for scientific equipment valued at $24,984.12, with completion required by January 31, 2021. Performance takes place in Germantown, Maryland. The order is priced on a firm fixed price basis.</p>
- <p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480 on June 9, 2020, with an ultimate completion date of June 14, 2021. Work is performed in Germantown, Maryland. The order is firm fixed price with no set-aside category. No additional source material specifies the scope of services or supplies procured under this purchase order.</p>
- The National Cancer Institute awarded a $24,731 firm fixed-price purchase order to Qiagen, LLC on August 12, 2021, for laboratory equipment with an ultimate completion date of October 10, 2021. This contract was issued without a set-aside designation and was to be performed in Germantown, Maryland, where Qiagen's U.S. subsidiary is headquartered. The award represents an administrative de-obligation of unexpended and expiring Fiscal Year 2021 funding in preparation for the September 30, 2026...
- <p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480.00 on March 30, 2020, with performance completion by March 31, 2021. Work is performed in Bethesda, Maryland. This firm fixed-price purchase order acquired molecular diagnostics products or services—specific scope details are not provided in the award documentation.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for service agreement work. Qiagen, a subsidiary of Qiagen N.V., will perform the services at its location in Bethesda, Maryland under the firm fixed price contract, which runs from September 1, 2023 through August 31, 2024. The award provides services to support the National Cancer Institute's research efforts as it works to prevent and cure cancer....
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for maintenance agreement services. Qiagen, LLC is a division of Qiagen N.V., a global life sciences company, and will perform the services at its location in Bethesda, Maryland between August 2023 and August 2024 under firm fixed pricing. The award provides support for an existing Qiagen product or solution under a one-year period of performance...
- The NIH Clinical Center awarded a purchase order to Qiagen, LLC on June 13, 2018, with a ceiling value of $216,766.82 for firm fixed-price delivery of QIAGEN products and services. The order's ultimate completion date was December 31, 2020. Place of performance is Valencia, California. This purchase order is now being administratively de-obligated to close unexpended fiscal year 2021 funding in preparation for the September 30, 2026 period-of-availability closing, in accordance with 31 U.S.C....
- <p>The National Cancer Institute awarded a purchase order to Qiagen, LLC valued at $6,021.00 on August 22, 2017 for service agreements supporting QIAxcel and QIACube instruments. Performance is at Bethesda, Maryland. The purchase order provides maintenance and support services to ensure continued availability of these sample preparation and analysis instruments. Performance concludes on September 20, 2018.</p>
- <p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for one QIAsymphony SP System valued at $93,067.38 on August 19, 2020. The instrument supports the National Cancer Institute's Cancer Center for Research Laboratory of Pathology at its Germantown, Maryland location. The order carries firm fixed pricing and ultimate completion was scheduled for September 20, 2020. No small business set-aside applied.</p>
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...